Get the Stockscreener App
1.66
2.47%
0.04
After Hours:
1.65
-0.01
-0.60%
Organigram Holdings Inc stock is traded at $1.66, with a volume of 1.97M.
It is up +2.47% in the last 24 hours and down -1.19% over the past month.
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds brands, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.
See More
Previous Close:
$1.62
Open:
$1.61
24h Volume:
1.97M
Relative Volume:
2.73
Market Cap:
$209.42M
Revenue:
$108.81M
Net Income/Loss:
$-186.70M
P/E Ratio:
-1.9715
EPS:
-0.842
Net Cash Flow:
$-16.83M
1W Performance:
+7.10%
1M Performance:
-1.19%
6M Performance:
+8.50%
1Y Performance:
-22.07%
1-Day Range:
$1.61
$1.74
1-Week Range:
$1.43
$1.74
52-Week Range:
$1.31
$2.91
Organigram Holdings Inc Stock (OGI) Company Profile
Compare OGI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGI
Organigram Holdings Inc
|
1.66 | 209.42M | 108.81M | -186.70M | -16.83M | -0.842 |
|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Organigram Holdings Inc Stock (OGI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-24 | Resumed | Canaccord Genuity | Speculative Buy |
| Apr-15-24 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Jan-13-23 | Upgrade | Stifel | Hold → Buy |
| Jan-12-22 | Upgrade | Canaccord Genuity | Hold → Speculative Buy |
| May-11-21 | Upgrade | CIBC | Sector Underperform → Neutral |
| Apr-14-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-08-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Mar-10-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-13-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Jan-13-21 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jul-07-20 | Initiated | Alliance Global Partners | Buy |
| Jan-15-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-13-20 | Initiated | BofA/Merrill | Underperform |
| Jan-09-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-12-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-11-19 | Upgrade | Jefferies | Hold → Buy |
View All
Organigram Holdings Inc Stock (OGI) Latest News
Organigram (OGI) to Release Quarterly Earnings on Tuesday - MarketBeat
Organigram (TSE:OGI) Shares Down 4.5%Time to Sell? - MarketBeat
Organigram Holdings to Announce Q1 Fiscal 2025 Results - TipRanks
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 - The Bakersfield Californian
Organigram (TSE:OGI) Shares Down 4.5% – Here’s What Happened - Defense World
Head-To-Head Survey: Oncternal Therapeutics (NASDAQ:ONCT) & Organigram (NASDAQ:OGI) - Defense World
OGIOrganigram Announces $60 Million Underwritten Public Offering - ADVFN Logo
OGI (OrganiGram Holdings) Debt-to-Revenue : 0.03 (As of Sep. 2024) - GuruFocus.com
OGI (OrganiGram Holdings) 3-Year Book Growth Rate : -22.90% (As of Sep. 2024) - GuruFocus.com
OrganiGram Holdings (NASDAQ:OGI) Stock Quotes, Forecast and News Summary - Benzinga
Cannabidiol Cbd Water Market Expected to Boom at 13.89% CAGR to Hit 7.183 Billion USD by 2032 | Organigram - EIN News
OrganiGram Holdings (FRA:0OG0) Operating Cash Flow per Shar - GuruFocus.com
Organigram (NASDAQ:OGI) Shares Down 1.3% – Should You Sell? - Defense World
Organigram (NASDAQ:OGI) Trading Down 1.3% – Here’s What Happened - Defense World
Organigram (NASDAQ:OGI) Trading Down 1.3%What's Next? - MarketBeat
OrganiGram Holdings (FRA:0OG0) Cash Flow for Lease Financin - GuruFocus.com
OrganiGram Holdings (FRA:0OG0) Long-Term Capital Lease Obli - GuruFocus.com
OrganiGram Holdings (FRA:0OG0) Free Cash Flow per Share : €0.02 (TTM As of Sep. 2024) - GuruFocus.com
Organigram (TSE:OGI) Stock Price Down 0.4%Here's Why - MarketBeat
OrganiGram Holdings (STU:0OG0) EPS without NRI : €-0.34 (TTM As of Sep. 2024) - GuruFocus.com
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On - Benzinga
Why OrganiGram (OGI) Is Among the Best Pot Stocks to Invest in According to Analysts? - Yahoo Finance
10 Best Pot Stocks To Invest In According to Analysts - Insider Monkey
Canada’s Organigram shops for U.S. pot businesses with backing from British American Tobacco - MSN
Atb Cap Markets Predicts Organigram Q1 Earnings - MarketBeat
Alliance Global Partners Comments on Organigram Q1 Earnings - MarketBeat
Alliance Global Partners Predicts Organigram Q1 Earnings - MarketBeat
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade) - Seeking Alpha
Atb Cap Markets Estimates Organigram’s Q4 Earnings (TSE:OGI) - Defense World
Organigram Reports Fourth Quarter and Fiscal 2024 Results - Business Wire
OrganiGram Holdings Inc. (NASDAQ:OGI) Q4 2024 Earnings Call Transcript - Insider Monkey
Atb Cap Markets Estimates Organigram Q4 Earnings - MarketBeat
Atb Cap Markets Forecasts Organigram Q3 Earnings - MarketBeat
Small caps to watch: Shares in Canadian fashion retailer slide after disappointing quarter - The Globe and Mail
FY2025 EPS Estimates for Organigram Cut by Atb Cap Markets - MarketBeat
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Organigram eyes global cannabis growth after Motif deal - Green Market Report
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion - GuruFocus.com
OrganiGram: Fiscal Q4 Earnings Snapshot - CT Insider
OrganiGram Holdings Inc (OGI) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
The small-cap rally has its skeptics: Morning Brief [Video] - AOL
Organigram Holdings: Fiscal 2024 Financial Highlights - TipRanks
Organigram (OGI) Q4 2024 Earnings Call Transcript - The Motley Fool
Organigram Reports Revenue Growth in Fiscal 2024, But Net Losses Continue - The Deep Dive
Organigram (NASDAQ:OGI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Organigram tops estimates, expands international reach ahead of major deal - Green Market Report
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars - Benzinga
OrganiGram Holdings 4Q Profit, Revenue Rise - MarketWatch
Organigram Acquires Motif Labs, Becomes Canada’s Largest Cannabis Company - Yahoo Finance
Organigram Increases Revenue and Adjusted EBITDA in Q4 - New Cannabis Ventures
OrganiGram Holdings Q4 Earnings AssessmentOrganiGram Holdings (NASDAQ:OGI) - Benzinga
Organigram Holdings Inc Stock (OGI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):